1. Home
  2. NECB vs ANNX Comparison

NECB vs ANNX Comparison

Compare NECB & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NorthEast Community Bancorp Inc.

NECB

NorthEast Community Bancorp Inc.

HOLD

Current Price

$23.45

Market Cap

282.4M

Sector

Finance

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$6.29

Market Cap

334.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NECB
ANNX
Founded
1934
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.4M
334.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NECB
ANNX
Price
$23.45
$6.29
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$16.50
AVG Volume (30 Days)
51.3K
2.8M
Earning Date
02-02-2026
03-02-2026
Dividend Yield
4.35%
N/A
EPS Growth
N/A
N/A
EPS
3.21
N/A
Revenue
$102,569,000.00
N/A
Revenue This Year
$1.90
N/A
Revenue Next Year
$6.93
N/A
P/E Ratio
$7.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.27
$1.29
52 Week High
$25.93
$6.83

Technical Indicators

Market Signals
Indicator
NECB
ANNX
Relative Strength Index (RSI) 63.95 N/A
Support Level $22.50 N/A
Resistance Level $23.27 N/A
Average True Range (ATR) 0.60 0.00
MACD -0.03 0.00
Stochastic Oscillator 91.21 0.00

Price Performance

Historical Comparison
NECB
ANNX

About NECB NorthEast Community Bancorp Inc.

NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: